KEGG   Neomonachus schauinslandi (Hawaiian monk seal): 110573034
Entry
110573034         CDS       T08474                                 
Symbol
IL2
Name
(RefSeq) interleukin-2
  KO
K05429  interleukin 2
Organism
nsu  Neomonachus schauinslandi (Hawaiian monk seal)
Pathway
nsu04060  Cytokine-cytokine receptor interaction
nsu04061  Viral protein interaction with cytokine and cytokine receptor
nsu04151  PI3K-Akt signaling pathway
nsu04625  C-type lectin receptor signaling pathway
nsu04630  JAK-STAT signaling pathway
nsu04658  Th1 and Th2 cell differentiation
nsu04659  Th17 cell differentiation
nsu04660  T cell receptor signaling pathway
nsu04672  Intestinal immune network for IgA production
nsu04940  Type I diabetes mellitus
nsu05135  Yersinia infection
nsu05142  Chagas disease
nsu05162  Measles
nsu05166  Human T-cell leukemia virus 1 infection
nsu05171  Coronavirus disease - COVID-19
nsu05200  Pathways in cancer
nsu05320  Autoimmune thyroid disease
nsu05321  Inflammatory bowel disease
nsu05330  Allograft rejection
nsu05332  Graft-versus-host disease
Brite
KEGG Orthology (KO) [BR:nsu00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04630 JAK-STAT signaling pathway
    110573034 (IL2)
   04151 PI3K-Akt signaling pathway
    110573034 (IL2)
  09133 Signaling molecules and interaction
   04060 Cytokine-cytokine receptor interaction
    110573034 (IL2)
   04061 Viral protein interaction with cytokine and cytokine receptor
    110573034 (IL2)
 09150 Organismal Systems
  09151 Immune system
   04625 C-type lectin receptor signaling pathway
    110573034 (IL2)
   04660 T cell receptor signaling pathway
    110573034 (IL2)
   04658 Th1 and Th2 cell differentiation
    110573034 (IL2)
   04659 Th17 cell differentiation
    110573034 (IL2)
   04672 Intestinal immune network for IgA production
    110573034 (IL2)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    110573034 (IL2)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    110573034 (IL2)
   05171 Coronavirus disease - COVID-19
    110573034 (IL2)
   05162 Measles
    110573034 (IL2)
  09171 Infectious disease: bacterial
   05135 Yersinia infection
    110573034 (IL2)
  09174 Infectious disease: parasitic
   05142 Chagas disease
    110573034 (IL2)
  09163 Immune disease
   05320 Autoimmune thyroid disease
    110573034 (IL2)
   05321 Inflammatory bowel disease
    110573034 (IL2)
   05330 Allograft rejection
    110573034 (IL2)
   05332 Graft-versus-host disease
    110573034 (IL2)
  09167 Endocrine and metabolic disease
   04940 Type I diabetes mellitus
    110573034 (IL2)
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04052 Cytokines and neuropeptides [BR:nsu04052]
    110573034 (IL2)
   00536 Glycosaminoglycan binding proteins [BR:nsu00536]
    110573034 (IL2)
Cytokines and neuropeptides [BR:nsu04052]
 Cytokines
  Interleukins
   110573034 (IL2)
Glycosaminoglycan binding proteins [BR:nsu00536]
 Heparan sulfate / Heparin
  Cytokines
   110573034 (IL2)
SSDB
Motif
Pfam: IL2
Other DBs
NCBI-GeneID: 110573034
NCBI-ProteinID: XP_021537155
UniProt: A0A2Y9GGP3
LinkDB
Position
2:100991778..100996986
AA seq 154 aa
MYKMQLLSCIALTLVLVANSAPTTSSTKETQQQLEQLLLDLRLLLNGVNNYEDPKLSRML
TFKFYTPKKATELTHLQCLAEELKLLEEVLYLAQSKNFHSTDIKELMSNINVTLLKLKGS
ETRFKCEYDDETATITEFLNKWITFCQSIFSTLT
NT seq 465 nt   +upstreamnt  +downstreamnt
atgtacaaaatgcaactcttgtcttgcatcgcactgactcttgtacttgtcgcaaacagt
gcacctactacttcgtctacaaaggaaacacagcaacagttggagcaattgctgctggat
ttacggttgctcttgaatggagttaataattatgaggaccctaaactctccaggatgctc
acgtttaaattctacacgcccaagaaggccacagaattgacacatcttcagtgtctagca
gaagaactcaaacttctggaggaagtgctatatttagctcaaagcaaaaactttcactcg
acagacatcaaggaattaatgagcaatatcaatgtaacacttctgaaactaaagggatct
gaaacaagattcaaatgtgaatatgatgacgagacagcaaccattacagaatttctgaac
aaatggattactttttgtcaaagcatcttctcaacactgacttga

DBGET integrated database retrieval system